Literature DB >> 8223776

Avid thallium-201 uptake in hepatic carcinoid metastases.

R Nour1, R J Quinn, D L Morris, S P Butler.   

Abstract

While radiolabelled somatostatin analogues sensitively detect extrahepatic carcinoid tumour, intrahepatic metastases are frequently not visualised due to somatostatin accumulation in normal hepatic tissues. We report a case of avid thallium-201 uptake in multiple hepatic carcinoid metastases using single-photon emission tomography (SPET) and compare this to a SPET technetium-99m sulphur colloid scan in the same patient. The 99mTc sulphur colloid images demonstrate multiple focal defects at the site of known metastases in the hepatic right lobe (confirmed on both CT and surgery). However, there is avid uptake of thallium in the metastases on comparative SPET slices. 201Tl may be a useful agent for the detection and localisation of carcinoid tumour and in particular of intrahepatic carcinoid metastases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223776     DOI: 10.1007/bf00180912

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

1.  Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors.

Authors:  J C Reubi; W H Häcki; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

2.  Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.

Authors:  S W Lamberts; W H Bakker; J C Reubi; E P Krenning
Journal:  Metabolism       Date:  1990-09       Impact factor: 8.694

3.  Accumulation of 99mTc-DPD and 201TI in thyroid metastasis from carcinoid tumour.

Authors:  M Vorne; J Lavonen
Journal:  Rofo       Date:  1990-08

4.  Thallium-201 SPECT imaging of brain tumors: methods and results.

Authors:  K T Kim; K L Black; D Marciano; J C Mazziotta; B H Guze; S Grafton; R A Hawkins; D P Becker
Journal:  J Nucl Med       Date:  1990-06       Impact factor: 10.057

Review 5.  201Tl as a tumour-localizing agent: current status and future considerations.

Authors:  A H Elgazzar; M Fernandez-Ulloa; E B Silberstein
Journal:  Nucl Med Commun       Date:  1993-02       Impact factor: 1.690

6.  Somatostatin-receptor imaging in the localization of endocrine tumors.

Authors:  S W Lamberts; W H Bakker; J C Reubi; E P Krenning
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

7.  201Tl scintigraphy in the staging of lung cancer, breast cancer and lymphoma.

Authors:  A M Sehweil; J H McKillop; R Milroy; M A Sayed; G Ziada; S W Banham; K G Davidson; A Ragib; Y T Omar; H M Abdel-Dayem
Journal:  Nucl Med Commun       Date:  1990-04       Impact factor: 1.690

8.  Biodistributions of 201Tl in tumor bearing animals and inflammatory lesion induced animals.

Authors:  A Ando; I Ando; M Katayama; S Sanada; T Hiraki; H Mori; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1987

9.  Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors.

Authors:  J M Feldman; R A Blinder; K J Lucas; R E Coleman
Journal:  J Nucl Med       Date:  1986-11       Impact factor: 10.057

10.  Effect of hepatic cryotherapy on serum CEA concentration in patients with multiple inoperable hepatic metastases from colorectal cancer.

Authors:  R M Charnley; M Thomas; D L Morris
Journal:  Aust N Z J Surg       Date:  1991-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.